SALT SUBSTITUTES FROM A PHARMACEUTICAL POINT OF VIEW

被引：0

|

作者：

PICH, CH

MOEST, T

机构：

来源：

AKTUELLE ERNAHRUNGSMEDIZIN | 1981年 / 6卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：127 / 130

页数：4

相关论文

共 50 条

[21] The view from the pharmaceutical industry
Blackledge, GRP
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S127 - S127
[22] Spectroscopic methods for characterization of nonviral gene delivery systems from a pharmaceutical point of view
Welz, C
Fahr, A
APPLIED SPECTROSCOPY REVIEWS, 2001, 36 (04) : 333 - 397
[23] A Look at Salt Substitutes
Banman, Christine
JOURNAL OF RENAL NUTRITION, 2012, 22 (02) : E15 - E16
[24] POTASSIUM AND SALT SUBSTITUTES
HADDAD, A
AMERICAN HEART JOURNAL, 1978, 95 (01) : 134 - 135
[25] SALT SUBSTITUTES - A WARNING
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 139 (09): : 588 - 588
[26] SALT-SUBSTITUTES
DISTLER, A
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (17) : 703 - 703
[27] USE OF SALT SUBSTITUTES
FOX, GN
JOURNAL OF FAMILY PRACTICE, 1990, 30 (06): : 632 - &
[28] POTASSIUM IN SALT SUBSTITUTES
HADDAD, A
STRONG, E
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (20): : 1082 - 1082
[29] Methodology and complexity of megatrials:: Point-of-view of the pharmaceutical industry
Hernández, G
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (06): : 295 - 295
[30] The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
Fabio Arpinelli
Francesco Bamfi
Health and Quality of Life Outcomes, 4

← 1 2 3 4 5 →